Analysis of the Trans-Pacific Partnership's (TPP) intellectual property rights chapter indicates that the final text of the agreement is the result of legitimate compromise. Thus, concerns over the procedural dynamics of negotiating such an agreement may be somewhat overblown. Moreover, concerns over substantive aspects of the TPP may also be somewhat unfounded, as the TPP establishes a sensible regulatory regime for pharmaceutical products, providing strong incentives to innovate while safeguarding access to affordable medicines. Additionally, the TPP provides the United States with access to foreign markets, labor, and investment opportunities. Thus, Democrats and Republicans in both chambers of Congress should press the Trump administration to reverse its decision to withdraw and vote in favor of the TPP's implementing legislation, should such an opportunity arise.
Exploring the Trans-Pacific Partnership's Complexities Through the Lens of Its Intellectual Property Rights Chapter,
Emory Int'l L. Rev.
Available at: https://scholarlycommons.law.emory.edu/eilr/vol31/iss3/4